Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2014 Oct 29;15:419. doi: 10.1186/1745-6215-15-419

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© Gillard et al.; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

PMC Copyright notice

Neutralising antibody response against the heterologous A/Indonesia/05/2005 strain in the AS03 _A -adjuvanted groups. Vaccination groups are: 1xH5N1-AS, single dose of the AS03_A-adjuvanted vaccine; 1xH5N1, single dose of the non-adjuvanted vaccine; 2xH5N1-AS, double dose of the AS03_A-adjuvanted vaccine; 2xH5N1, double dose of the non-adjuvanted vaccine. Seroconversion rate (SCR) was defined as the percentage of vaccinees with a ≥4-fold increase in neutralising antibody titre at post-vaccination. GMT, geometric mean titre. Error bars indicate the 95% confidence intervals. Post-vaccination = day 42. Post-vaccination results are shown for a subset of the according-to-protocol immunogenicity cohort (1xH5N1-AS: N =87, 2xH5N1-AS: N =82), month 12 and month 24 results for a subset of the month 24 according-to-protocol persistence cohort (1xH5N1-AS: N =51, 2xH5N1-AS: N =54); N = maximum number of participants with available results.